Los anlogos de GLP-1 se han asociado con la reduccin de peso, el control de glucosa, la disminucin en la progresin de la diabetes y la mejora de sus complicaciones, tales como el hgado graso o la neuropata
Its active ingredient, semaglutide, is a GLP-1 receptor agonist (the same class of drugs that includes tirzepatide and liraglutide)
The trial protocols and subject information/informed consent forms were reviewed and approved by independent ethics committees (Capenhurst Independent Research Ethics Committee and Ethik-Kommission des Landes Berlin, respectively), and by appropriate health authorities according to local regulations
It also said the drug has been used for over a decade, has been extensively studied and that gastroparesis can have a variety of causes
This increase triggers several changes in appetite control and metabolism, making it easier for users to gradually reduce weight without feeling overly deprived or too hungry